On one side, some authors theorized that NSAIDs may have a negative impact on COVID-19 clinical outcomes [8,12,15], and Leal et al. suggested a potentially protective role of paracetamol due to its effect in decreasing the Angiotensin-Converting Enzyme 2 (ACE2) expression [13,16]. The gene discussed is ACE2; the disease is COVID-19.